多药在心血管疾病预防和治疗中的作用
Leonardo DE Luca1, Simone P Crispino2, Federico Andreoli3
1Division of Cardiology, Department of Cardio-Thoraco-Vascular Sciences, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy - l.deluca@smatteo.pv.it.
Minerva cardiology and angiology
|October 8, 2024
概括
多药丸是心血管药物的单剂量形式,在改善药物坚持和减少心血管事件方面表现有前途. 需要进一步的研究来证实其与单个治疗相比的长期益处.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 多种药丸概念提供了一种策略,以改善坚持和管理心血管风险因素.
- 低收入和中等收入国家中心血管疾病负担的增加需要创新的解决方案.
研究的目的:
- 审查多药丸对主要心血管事件 (MACE) 影响的证据.
- 评估多种药丸对药物坚持的影响及其成本效益.
- 探讨多药剂实施的挑战和未来的研究需求.
主要方法:
- 临床试验和观察性研究的审查.
- 对MACE发生率,药物坚持和药物经济学数据的分析.
- 在预防心血管疾病方面评估多药药的有效性,安全性和成本效益.
主要成果:
- 多种药丸显示出改善治疗顺应性和减少心血管风险因素的潜力.
- 证据表明,在心血管疾病预防中使用多药丸具有有利的概况.
- 关于其与个性化治疗相比比较有效性的辩论仍在继续.
结论:
- 多种药丸是心血管疾病管理的一个有希望的策略,增强了坚持并可能减少事件.
- 需要进一步的大规模随机对照试验来验证长期益处并解决实施挑战.
- 针对个体风险概况调整多药组件对于最佳结果至关重要.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
483
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
483
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Peripheral Artery Disease III: Interprofessional Care
3
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3
Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K


